partners

Experimentica Ltd. is a Finnish contract research organization (CRO) specializing in preclinical ophthalmic disease models. Experimentica bridges the gap between novel ocular model development and clinical applications using a diverse array of skills and industry experience, from cell cultures to intricate surgeries and in vivo models. Operating from Finland, Lithuania, and the USA, Experimentica has conducted extensive preclinical studies for global pharmaceutical and biotech companies over the past 10 years, utilizing rodent and non-rodent models for retinopathy, toxicity, and compound evaluation.

Vichem Chemie Research Ltd. was founded in 1999 by Axxima Pharmaceuticals as its Hungarian medicinal chemistry subsidiary for drug discovery in the kinase field. Vichem became an independent private company via management buyout in 2005. Vichem (The Kinase Inhibitor Company”) is a research company engaged in rational drug design of kinase inhibitors for signal transduction therapy. Business strategy of Vichem is providing medicinal chemistry services and contract research, drug discovery and preclinical lead development for partners and development of own compounds. Products are early and late stage preclinical documentations of various kinase inhibitor compounds.

With an outstanding international ranking of 295th in life and medical sciences among Hungarian Universities, Semmelweis University has proven itself as a leader in academia. Notably, the university excels in anatomy and psychology, securing a position among the top 100 higher education institutions (51-100) in the Quacquarelli Symonds (QS) World University Rankings.
Within Semmelweis University, the tasks related to NeoVasculoStop are carried out by the Translational Retina Research Group established by Dr. Krisztián Kovács in the Institute of Translational Medicine

Izmir Biomedicine and Genome Center (IBG) is a biomedical research centre in Türkiye dedicated to developing innovative technologies and products for disease prevention, diagnosis and treatment. Based at Dokuz Eylül University’s health campus in Izmir, IBG combines fundamental life sciences research with translational and applied research in biomedicine and genome sciences. Its expertise spans vaccine and biopharmaceutical development, cell-based products, biomedical technologies, omics, computational biology, and rare diseases. With approximately 26,650 m² of laboratory and office space and nine core facilities, IBG provides advanced research infrastructure, including facilities accessible to public and private sector institutions, to support scientific discovery and healthcare innovation.

LC Innoconsult (Laser Consult Ltd) (LCIN) is an international innovation management consultancy (SME) founded in 1992. The basis of our successful operation and the philosophy of our company is the importance of cooperation and networking. We have provided services as an external service provider for more than 60 FP7 and H2020 projects. As a project partner, we have participated in 6 H2020 projects, 2 Horizon Europe and 1 Pathfinder project, of which the company acted as WP leader for exploitation and knowledge management in 5 projects.